Retractable Technologies (RVP) Depreciation & Amortization (CF) (2010 - 2026)
Retractable Technologies (RVP) reported Depreciation & Amortization (CF) of $1.9 million for Q1 2026, up 1.16% on a YoY basis from $1.9 million in Q1 2025, and down 11.17% quarter-over-quarter from $2.1 million in Q4 2025.
Retractable Technologies (RVP) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Retractable Technologies has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 1.16% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.8 million (up 2.97% YoY), and the FY2025 full-year result was $7.8 million, up 2.59% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $1.9 million, down from $2.1 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $2.1 million in Q4 2025, with the low at $696846.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $1.7 million across 5 years, with a median of $1.9 million in 2024.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 393.61% — and 2024, when it declined 3.02%.
- Retractable Technologies' Depreciation & Amortization (CF) stood at $1.6 million in 2022, then gained by 5.12% to $1.7 million in 2023, then rose by 10.9% to $1.9 million in 2024, then advanced by 13.67% to $2.1 million in 2025, then retreated by 11.17% to $1.9 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $1.9 million (Q1 2026), $2.1 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Retractable Technologies | 19.78 Mn | -15.84 Mn | -838,408.00 | 1.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Dec 31, 2023 | 1.70 Mn |